Markus Müller

Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel.

J. von Hardenberg, C. Bolenz, C. Weiss, 2017, Anticancer research.

Matrix metalloproteinase-19 expression in normal and diseased skin: dysregulation by epidermal proliferation.

R. Sedláček, B. Havlíčková, E. Proksch, 2003, The Journal of investigative dermatology.

Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel

J. Soutschek, A. Geick, H. Vornlocher, 2007, Anti-cancer drugs.

Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer

J. von Hardenberg, P. Erben, C. Bolenz, 2018, Oncology Research and Treatment.

Influence of abiraterone acetate on circulating neuromediators in chemotherapy‐naïve castration‐resistant prostate cancer

J. von Hardenberg, C. Bolenz, C. Weiss, 2016, The Prostate.

Small interfering RNA targeting bcl-2 sensitizes malignant melanoma.

H. Pehamberger, A. Geick, P. Hadwiger, 2003, Oligonucleotides.